Geron Corporation
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Geron Corporation now
Current reporting with the operating signal separated from the noise.
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The story matters when it changes Geron Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Geron Corporation
The story matters when it changes Geron Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
The story matters when it changes Geron Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
The story matters when it changes Geron Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
The story matters when it changes Geron Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
The story matters when it changes Geron Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Geron Corporation's (GERN) CEO John Scarlett on Q4 2018 Results
The story matters when it changes Geron Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Why Geron Corporation Shares Were Mauled
Investors are testing whether Geron Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest GERN filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Geron Corporation, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →